£95.73

Springer - Migraine and Headache Disorders Global Perspective

Price data last checked 28 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

New to our records — first sighting 28 days ago. We'll learn its rhythm.

28 days of data · current price £96

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 1 days · 1 data points (no recent data)

Historical
Generating forecast…
Not enough data points to display chart (need at least 2 points)

Price Distribution

Price distribution over 1 days • 1 price levels

Days at Price
1 day 0 0 1 1 1 £96 Days at Price

Price Analysis

Most common price: £96 (1 days, 100.0%)

Price range: £96 - £96

Price levels: 1 different prices over 1 days

Description

Explore a comprehensive look at neurological health with Migraine and Headache Disorders: The Global Perspective. Published by Springer as part of the Sustainable Development Goals Series, this book provides a wide-ranging view of headache disorders from a global standpoint. This text is a valuable resource for medical professionals, researchers, and students interested in neurology and clinical neurophysiology. It addresses the complexities of headache disorders within a global framework, making it a significant addition to any medical library focused on internal medicine. By examining these conditions through a global lens, the book offers a perspective that is essential for understanding the health challenges faced by diverse populations worldwide. Whether you are studying neurology or practicing internal medicine, this volume provides the necessary context to understand the broader impact of these disorders on public health.

Key Features

Part of the Sustainable Development Goals Series from Springer, providing a specialized academic perspective.

Focuses on migraine and headache disorders through a global lens for a wide-reaching understanding.

Categorized under Neurology and Clinical Neurophysiology for targeted medical study and reference.

Ideal for medical healthcare practitioners specializing in internal medicine and neurology.

Provides a global perspective on headache disorders to support research and clinical practice.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
07 February 2026
Listed Since
13 November 2025

Barcode

No barcode data available

Similar Products You Might Like

Clinical Scales for Headache Disorders
98% match

Clinical Scales for Headache Disorders

Springer

£95.73 06 Jul 2026
Management of Migraine Pain: Emerging Opportunities and Challenges
98% match

Management of Migraine Pain: Emerging Opportunities and Challenges

Springer

£199.99 15 Jul 2026
Academic Press - Interventional Management of Migraines
98% match

Academic Press - Interventional Management of Migraines

Academic Press

£115.99 15 Jul 2026
Headache Disorders in Pandemic Conditions
98% match

Headache Disorders in Pandemic Conditions

Springer

£95.73 06 Jul 2026
Headache Disorders in Pandemic Conditions
98% match

Headache Disorders in Pandemic Conditions

Springer

£73.11 04 Jul 2026
Neuroimaging of Headache Disorders
98% match

Neuroimaging of Headache Disorders

Springer

£101.05 04 Jul 2026
The Biochemistry of Migraine
98% match

The Biochemistry of Migraine

Springer

£162.66 06 Jul 2026
Headache and Comorbidities in Childhood and Adolescence
98% match

Headache and Comorbidities in Childhood and Adolescence

Springer

£80.64 04 Jul 2026
Comorbid Conditions in the Treatment of Headache
98% match

Comorbid Conditions in the Treatment of Headache

CRC Press

£72.70 03 Jul 2026
Migraine, Words and Fiction
98% match

Migraine, Words and Fiction

Cambridge Scholars Publishing

£67.99 08 Jul 2026
Interventional Management of Headache Pain
97% match

Interventional Management of Headache Pain

Elsevier

£147.99 06 Jul 2026
Migraine
97% match

Migraine

IntechOpen

£119.00 03 Jul 2026
Monoclonal Antibodies in Headache: From Bench to Patient
97% match

Monoclonal Antibodies in Headache: From Bench to Patient

Springer

£71.84 08 Jul 2026
The 2023-2028 Outlook for Anti-Migraine Drugs in India
97% match

The 2023-2028 Outlook for Anti-Migraine Drugs in India

£515.00 19 Jun 2026
The 2023-2028 Outlook for Anti-Migraine Drugs in the United States
97% match

The 2023-2028 Outlook for Anti-Migraine Drugs in the United States

£520.00 18 Jun 2026
Traitements de crise et traitements de fond de la migraine: Aspects pharmacothérapeutiques (Omn.Univ.Europ.)
97% match

Traitements de crise et traitements de fond de la migraine: Aspects pharmacothérapeutiques (Omn.Univ.Europ.)

OmniScriptum

£70.00 13 Jul 2026
Diagnosis and Management of Head and Face Pain: A Practical Approach
97% match

Diagnosis and Management of Head and Face Pain: A Practical Approach

Springer

£81.80 15 Jul 2026
The 2016-2021 Outlook for Anti-Migraine Drugs in Latin America
97% match

The 2016-2021 Outlook for Anti-Migraine Drugs in Latin America

£425.00 18 Jun 2026
The 2016-2021 Outlook for Anti-Migraine Drugs in the United States
97% match

The 2016-2021 Outlook for Anti-Migraine Drugs in the United States

£595.00 17 Jun 2026
The 2016-2021 Outlook for Anti-Migraine Drugs in Greater China
97% match

The 2016-2021 Outlook for Anti-Migraine Drugs in Greater China

£595.00 19 Jun 2026
Headache: Evaluation and Management
97% match

Headache: Evaluation and Management

Foster Academics

£71.36 05 Jul 2026
The 2021-2026 World Outlook for Anti-Migraine Drugs
97% match

The 2021-2026 World Outlook for Anti-Migraine Drugs

£795.00 19 Jun 2026
The 2016-2021 Outlook for Anti-Migraine Drugs in Asia
97% match

The 2016-2021 Outlook for Anti-Migraine Drugs in Asia

£425.00 17 Jun 2026
The 2016-2021 Outlook for Anti-Migraine Drugs in Europe
97% match

The 2016-2021 Outlook for Anti-Migraine Drugs in Europe

£425.00 19 Jun 2026